Back to Search Start Over

Deciphering Intratumoral Molecular Heterogeneity in Clear Cell Renal Cell Carcinoma with a Radiogenomics Platform

Authors :
Michael Fulkerson
Jeffrey A. Cadeddu
Sydney Haldeman
Roy Elias
Qurratulain Yousuf
Qing Yuan
Vitaly Margulis
Alana Christie
Ananth J. Madhuranthakam
Robert C. Sibley
DK Dwivedi
James Brugarolas
Payal Kapur
Asghar Hajibeigi
Ze Zhang
Junyu Guo
Aditya Bagrodia
Matthew A. Lewis
Yin Xi
Tiffani McKenzie
Allison Joyce
Hollis Notgrass
Ivan Pedrosa
Tao Wang
Durga Udayakumar
Alberto Diaz de Leon
Renée M. McKay
Source :
Clin Cancer Res
Publication Year :
2021
Publisher :
American Association for Cancer Research (AACR), 2021.

Abstract

Purpose: Intratumoral heterogeneity (ITH) challenges the molecular characterization of clear cell renal cell carcinoma (ccRCC) and is a confounding factor for therapy selection. Most approaches to evaluate ITH are limited by two-dimensional ex vivo tissue analyses. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) can noninvasively assess the spatial landscape of entire tumors in their natural milieu. To assess the potential of DCE-MRI, we developed a vertically integrated radiogenomics colocalization approach for multi-region tissue acquisition and analyses. We investigated the potential of spatial imaging features to predict molecular subtypes using histopathologic and transcriptome correlatives. Experimental Design: We report the results of a prospective study of 49 patients with ccRCC who underwent DCE-MRI prior to nephrectomy. Surgical specimens were sectioned to match the MRI acquisition plane. RNA sequencing data from multi-region tumor sampling (80 samples) were correlated with percent enhancement on DCE-MRI in spatially colocalized regions of the tumor. Independently, we evaluated clinical applicability of our findings in 19 patients with metastatic RCC (39 metastases) treated with first-line antiangiogenic drugs or checkpoint inhibitors. Results: DCE-MRI identified tumor features associated with angiogenesis and inflammation, which differed within and across tumors, and likely contribute to the efficacy of antiangiogenic drugs and immunotherapies. Our vertically integrated analyses show that angiogenesis and inflammation frequently coexist and spatially anti-correlate in the same tumor. Furthermore, MRI contrast enhancement identifies phenotypes with better response to antiangiogenic therapy among patients with metastatic RCC. Conclusions: These findings have important implications for decision models based on biopsy samples and highlight the potential of more comprehensive imaging-based approaches.

Details

ISSN :
15573265 and 10780432
Volume :
27
Database :
OpenAIRE
Journal :
Clinical Cancer Research
Accession number :
edsair.doi.dedup.....44f601fde59df962a3b6d96f778e7269
Full Text :
https://doi.org/10.1158/1078-0432.ccr-21-0706